BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 17659823)

  • 21. Patient-rated troubling symptoms of depression instrument results correlate with traditional clinician- and patient-rated measures: a secondary analysis of a randomized, double-blind, placebo-controlled trial.
    Pandina GJ; Revicki DA; Kleinman L; Turkoz I; Wu JH; Kujawa MJ; Mahmoud R; Gharabawi GM
    J Affect Disord; 2009 Nov; 118(1-3):139-46. PubMed ID: 19321206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study.
    Siwek M; Dudek D; Paul IA; Sowa-Kućma M; Zieba A; Popik P; Pilc A; Nowak G
    J Affect Disord; 2009 Nov; 118(1-3):187-95. PubMed ID: 19278731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the efficacy of desvenlafaxine for improving functioning and well-being outcome measures in patients with major depressive disorder: a pooled analysis of 9 double-blind, placebo-controlled, 8-week clinical trials.
    Soares CN; Kornstein SG; Thase ME; Jiang Q; Guico-Pabia CJ
    J Clin Psychiatry; 2009 Oct; 70(10):1365-71. PubMed ID: 19906341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced mania and depression in juvenile bipolar disorder associated with long-chain omega-3 polyunsaturated fatty acid supplementation.
    Clayton EH; Hanstock TL; Hirneth SJ; Kable CJ; Garg ML; Hazell PL
    Eur J Clin Nutr; 2009 Aug; 63(8):1037-40. PubMed ID: 19156158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy, safety, and tolerability of fixed-dose desvenlafaxine 50 and 100 mg/day for major depressive disorder in a placebo-controlled trial.
    Boyer P; Montgomery S; Lepola U; Germain JM; Brisard C; Ganguly R; Padmanabhan SK; Tourian KA
    Int Clin Psychopharmacol; 2008 Sep; 23(5):243-53. PubMed ID: 18703933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of tuna fish oil on hyperlipidemia and proteinuria in childhood nephrotic syndrome.
    Chongviriyaphan N; Tapaneya-Olarn C; Suthutvoravut U; Karnchanachumpol S; Chantraruksa V
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S122-8. PubMed ID: 10730531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE; Ackl N; Hatzinger M; Held K; Holsboer-Trachsler E; Ising M; Kaschka W; Kasper S; Konstantinidis A; Sonntag A; Uhr M; Yassouridis A; Holsboer F; Steiger A
    J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-Chain Omega-3 Fatty Acid Supplements in Depressed Heart Failure Patients: Results of the OCEAN Trial.
    Jiang W; Whellan DJ; Adams KF; Babyak MA; Boyle SH; Wilson JL; Patel CB; Rogers JG; Harris WS; O'Connor CM
    JACC Heart Fail; 2018 Oct; 6(10):833-843. PubMed ID: 30098961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fish oil supplementation improves large arterial elasticity in overweight hypertensive patients.
    Wang S; Ma AQ; Song SW; Quan QH; Zhao XF; Zheng XH
    Eur J Clin Nutr; 2008 Dec; 62(12):1426-31. PubMed ID: 17805229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is duloxetine effective treatment for depression with atypical features?
    Stewart JW; Deliyannides DA; McGrath PJ
    Int Clin Psychopharmacol; 2008 Nov; 23(6):333-6. PubMed ID: 18854721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study.
    Chiu CC; Su KP; Cheng TC; Liu HC; Chang CJ; Dewey ME; Stewart R; Huang SY
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1538-44. PubMed ID: 18573585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study.
    Amminger GP; Berger GE; Schäfer MR; Klier C; Friedrich MH; Feucht M
    Biol Psychiatry; 2007 Feb; 61(4):551-3. PubMed ID: 16920077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary supplement use in people being treated for depression.
    Silvers KM; Woolley CC; Hedderley D
    Asia Pac J Clin Nutr; 2006; 15(1):30-4. PubMed ID: 16500875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of dietary omega-3 polyunsaturated fatty acids on experimental periodontitis in the mouse.
    Bendyk A; Marino V; Zilm PS; Howe P; Bartold PM
    J Periodontal Res; 2009 Apr; 44(2):211-6. PubMed ID: 19210341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of prescription omega-3 fatty acids on body weight after 8 to 16 weeks of treatment for very high triglyceride levels.
    Bays HE; Maki KC; Doyle RT; Stein E
    Postgrad Med; 2009 Sep; 121(5):145-50. PubMed ID: 19820283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
    J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of omega-3 fatty acid supplementation on lipid levels in endstage renal disease patients.
    Bowden RG; Jitomir J; Wilson RL; Gentile M
    J Ren Nutr; 2009 Jul; 19(4):259-66. PubMed ID: 19539180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of polyunsaturated fatty acids on the biochemical indices of bronchial asthma patients].
    Masuev KA
    Ter Arkh; 1997; 69(3):33-5. PubMed ID: 9229825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fish oil n-3 polyunsaturated fatty acids selectively affect plasma cytokines and decrease illness in Thai schoolchildren: a randomized, double-blind, placebo-controlled intervention trial.
    Thienprasert A; Samuhaseneetoo S; Popplestone K; West AL; Miles EA; Calder PC
    J Pediatr; 2009 Mar; 154(3):391-5. PubMed ID: 18930251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.